Endometrial Receptivity Analysis (ERA) test: an unproven technology

Area of Science:

• Reproductive Medicine
• Genomics
• Infertility Treatments

Background:

• The endometrial receptivity array (ERA) is a diagnostic tool used to determine the uterine window of implantation (WOI).
• ERA aims to personalize embryo transfer timing to improve pregnancy success rates.
• Concerns exist regarding the reliability and clinical utility of ERA in assisted reproductive technologies.

Purpose of the Study:

• To critically evaluate the limitations and potential drawbacks of the ERA methodology.
• To assess whether ERA significantly enhances implantation success rates in assisted reproduction.

Main Methods:

• Review of existing literature and clinical data on ERA methodology.
• Analysis of factors affecting endometrial receptivity and implantation.
• Discussion of limitations including biopsy variability, gene expression analysis, progesterone levels, and cryopreservation risks.

Main Results:

• ERA methodology faces challenges such as inconsistent endometrial biopsies and variable gene dysregulation without embryonal influence.
• The test does not account for serum progesterone levels and has limited applicability to a small patient subset.
• Difficulties in synchronizing the endometrium and risks associated with embryo cryopreservation are noted.

Conclusions:

• The clinical benefit of ERA in significantly enhancing implantation rates remains questionable.
• Further research and validation are needed to establish ERA as a reliable tool in fertility treatments.
• The current evidence does not strongly support routine use of ERA as an add-on procedure.